To date, studies to identify genetic modifiers of BRCA1/2 were mainly carried out in three ways: candidate gene studies, investigation of specific variants discovered by genome-wide association studies (GWAS) to associate with cancer risks in the general population, and GWAS carried out specifically in BRCA1 or BRCA2 carriers [13,16,17,18,19]. Here, BRCA1 is linked to cancer.